Armistice Capital, LLC 10x Genomics, Inc. Transaction History
Armistice Capital, LLC
- $7.34 Billion
- Q1 2024
A detailed history of Armistice Capital, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 158,286 shares of TXG stock, worth $3.08 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
158,286
Previous 92,000
72.05%
Holding current value
$3.08 Million
Previous $5.15 Million
15.38%
% of portfolio
0.08%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding TXG
# of Institutions
309Shares Held
92MCall Options Held
267KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA9.1MShares$177 Million0.01% of portfolio
-
Baillie Gifford & CO7.42MShares$144 Million0.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.28MShares$122 Million1.68% of portfolio
-
Black Rock Inc. New York, NY6.01MShares$117 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.16MShares$100 Million0.02% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.85B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...